Johnson & Johnson at Barclays Global Healthcare Conference Transcript
Good morning. Welcome to the third day of the Barclays Global Healthcare Conference. My name is Geoff Meacham, I'm the senior biopharma analyst here. And I have Kristen Stewart, our med device analyst up on stage as well. So we're thrilled to have Johnson & Johnson. And we have Tom Cavanaugh, who is President of Oncology, here to my right; and then Catherine Owen is President of Immunology to my right. And my -- to my left here is Chris DelOrefice from the IR team; and then Lesley Fishman, who's also from the IR team.
So we're just going to do a fireside chat today. But I think, Lesley, you wanted to read out the forward-looking statement, and then we can get right into it.
Thank you, Geoff. I promise to be brief. Please be aware that some statements made today may be considered forward-looking. Please refer to our SEC filings, in particular our 10-K, which discuss risks and uncertainties that could cause results to differ materially from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
